Division of Clinical Microbiology, Department of Laboratory Medicine, Medical University Vienna, Vienna, Austria.
J Clin Microbiol. 2013 May;51(5):1534-40. doi: 10.1128/JCM.00103-13. Epub 2013 Mar 13.
Time to detection (TTD) in automated blood culture systems is delayed for sensitive microorganisms in the presence of antimicrobial substances and has been associated with worse outcomes for sepsis patients on inadequate empirical therapy. While resin addition removes antimicrobial substances to various degrees from blood culture media, media formulations and the blend of resins may influence performance. The BacT/Alert 3D system (bioMérieux) was investigated using the new resin-containing medium types FA Plus (aerobic) and FN Plus (anaerobic). TTD was compared between control and test bottles containing relevant bacteria or Candida albicans, with and without defined concentrations of antimicrobials. Failure of neutralization was defined as a negative blood culture on day 3. In general, growth delay was nonlinear, concentration dependent, bottle type specific, and reciprocally associated with MICs. Substance-specific serum drug concentrations corresponding to a predefined, clinically relevant 3-h delay of TTD were calculated. Where appropriate, a time interval allowing for drug elimination below this critical level was obtained by pharmacokinetic modeling. Clarithromycin, clindamycin, gentamicin, linezolid, tigecycline, vancomycin, and fluconazole were neutralized. For ciprofloxacin and piperacillin-tazobactam, which were only incompletely neutralized in combination with the most sensitive test strains, a maximum waiting time for blood draw of 1 h was determined based on pharmacokinetics. One or more test strains did not grow in bottles containing either amoxicillin-clavulanate, cefepime, cefotaxime, meropenem, or metronidazole, and we thus recommend particular caution in timing of blood draws if patients have been pretreated with these agents.
检测时间(TTD)在自动化血培养系统中会因存在抗菌物质而延迟,并且与接受不充分经验性治疗的脓毒症患者的不良结局相关。虽然树脂添加可以在不同程度上去除血液培养介质中的抗菌物质,但介质配方和树脂混合物可能会影响性能。本研究使用新的含有树脂的 FA Plus(需氧)和 FN Plus(厌氧)培养基类型,对 BacT/Alert 3D 系统(bioMérieux)进行了研究。在含有相关细菌或白色念珠菌的对照和测试瓶中,比较了有和没有定义浓度的抗菌药物时 TTD 的差异。如果第 3 天的血培养呈阴性,则定义为中和失败。通常,生长延迟是非线性的、浓度依赖性的、瓶型特异性的,并且与 MIC 呈反向相关。根据药代动力学模型,计算出与 TTD 延迟 3 小时相关的、特定于物质的血清药物浓度。在适当的情况下,通过药代动力学模型获得允许药物消除至低于临界水平的时间间隔。克拉霉素、克林霉素、庆大霉素、利奈唑胺、替加环素、万古霉素和氟康唑被中和。对于环丙沙星和哌拉西林他唑巴坦,仅与最敏感的测试菌株联合使用时不能完全中和,根据药代动力学确定了最长 1 小时的采血等待时间。在含有阿莫西林克拉维酸、头孢吡肟、头孢噻肟、美罗培南或甲硝唑的瓶中,一种或多种测试菌株不能生长,因此如果患者已经使用这些药物进行预处理,我们建议特别注意采血时间。